Medicines labeled for the same conditions
Alternatives to travoprost
17 other medicines are given the same way (ophthalmic) and in the same FDA class as travoprost or labeled mainly for the same use (glaucoma); 4 are in its class, prostaglandin analogs: bimatoprost, latanoprost, tafluprost and latanoprost and netarsudil; the others include 4 beta-adrenergic blockers, 4 carbonic anhydrase inhibitors and 1 alpha-adrenergic agonist (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $1.58 per mL (Latanoprost 0.005% eye drops) (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as travoprost?
Glaucoma lists all 20 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (ophthalmic) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Travoprostprostaglandin analog | this medicine | 11 labelers | $9.07 per mL 0.004% eye drop | No | A presentation being discontinued |
| Bimatoprostprostaglandin analog · same class | Glaucoma | 13 labelers | $6.97 per mL 0.03% eye drops | No | No current entry |
| Latanoprostprostaglandin analog · same class | Glaucoma | 14 labelers | $1.58 per mL 0.005% eye drops | No | No current entry |
| Tafluprostprostaglandin analog · same class | Glaucoma | 3 labelers | $2.45 per unit 0.0015% eye drop | No | No current entry |
| Latanoprost and netarsudilrho kinase inhibitor · same class | Glaucoma | none listed | $139.40 per mL 0.02%-0.005% eye drp | No | No current entry |
| Timololbeta-adrenergic blocker | Glaucoma | 21 labelers | $0.774 per mL 0.5% eye drops | No | No current entry |
| Brimonidinealpha-adrenergic agonist | Glaucoma | 12 labelers | $9.06 per mL 0.1% drop | No | No current entry |
| Dorzolamide and timololcarbonic anhydrase inhibitor | Glaucoma | 14 labelers | $0.893 per mL Dorzolamide-timolol eye drops | No | No current entry |
| Brimonidine and timololbeta-adrenergic blocker | Glaucoma | 14 labelers | $2.15 per mL 0.2%-0.5% | No | No current entry |
| Dorzolamidecarbonic anhydrase inhibitor | Glaucoma | 14 labelers | $0.835 per mL 2% eye drops | No | No current entry |
| Pilocarpinecholinergic receptor agonist | Glaucoma | 2 labelers | $2.81 per mL 2% eye drops | No | A presentation being discontinued |
| Brinzolamidecarbonic anhydrase inhibitor | Glaucoma | 4 labelers | $9.00 per mL 1% eye drops | No | No current entry |
| Latanoprostene bunod | Glaucoma | 1 labeler | $102.27 per mL 0.024% eye solution | No | No current entry |
| Brimonidine and brinzolamidecarbonic anhydrase inhibitor | Glaucoma | none listed | $26.04 per mL 1%-0.2% eye drop | No | No current entry |
| Carteololbeta-adrenergic blocker | Glaucoma | 1 labeler | $1.63 per mL 1% eye drops | No | No current entry |
| Levobunololbeta-adrenergic blocker | Glaucoma | 1 labeler | $2.82 per mL 0.5% eye drops | No | No current entry |
| Netarsudilrho kinase inhibitor | Glaucoma | none listed | $131.68 per mL 0.02% eye solution | No | No current entry |
| Omidenepag isopropylprostaglandin e2 receptor agonist | Glaucoma | none listed | n/a | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Travoprost: the full record
- label, generics, price, shortages, recalls
- Bimatoprost vs travoprost
- two records side by side
- Travoprost vs latanoprost
- two records side by side
- Travoprost vs timolol
- two records side by side